In:
Journal of Cellular Biochemistry, Wiley, Vol. 111, No. 1 ( 2010-09), p. 179-186
Abstract:
Endothelial dysfunction is involved in various cardiovascular diseases such as atherosclerosis. Endothelial progenitor cells (EPCs) contribute to re‐endothelialization and neo‐vascularization, and the increase of EPCs in peripherial circulation benefits the prognosis of cardiovascular disease. However, little is known about the biological stimuli that initiate the proliferation and the maintenance of stem cell phenotype of EPCs. Here we reported that human umbilical vein blood derived EPCs expressed gene transcripts coding for Toll‐like receptor (TLR) 1–6, TLR8–10, TLR4 co‐receptor CD14, and myeloid differentiation factor 88 (MyD88), a TLR adaptor molecule. Protein expression of TLR2, 4, CD14, and MyD88 was also detected by FACS or Western blot. The activation of TLR4 by LPS modulated the expression of TLRs, induced the phosphorylation of NF‐κB, P38, and ERK42/44, and up‐regulated the gene expression of cytokines IL‐8, IFN‐α, IFN‐β, and TNF‐α, suggesting EPCs expressed functional TLR4. Unexpectedly LPS treatment failed to induce apoptosis in EPCs, but instead promoted cell proliferation of EPCs. Furthermore, the treatment of EPCs with LPS up‐regulated stem cell markers AC133 and CD34 in both mRNA and protein levels, and down‐regulated the protein expression of differential marker eNOS. These results suggested that TLR4 functions to maintain the stem cell phenotype of EPCs and enlarge its population, which reveals a novel aspect of the multiple‐faced TLR biology, and may open new prospects for using TLR4 agonists to promote the production of EPCs for clinical use. J. Cell. Biochem. 111: 179–186, 2010. © 2010 Wiley‐Liss, Inc.
Type of Medium:
Online Resource
ISSN:
0730-2312
,
1097-4644
Language:
English
Publisher:
Wiley
Publication Date:
2010
detail.hit.zdb_id:
1479976-5
detail.hit.zdb_id:
392402-6
SSG:
12
